Anti-cancer effects by the green tea catechins
绿茶儿茶素的抗癌作用
基本信息
- 批准号:6918263
- 负责人:
- 金额:$ 12.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-06 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:alternative medicineantineoplasticsapoptosisbiological productscarcinogenesis inhibitorcell linechemopreventioncolorectal neoplasmsflavonoidsgene expression profilinggene induction /repressiongenetic transcriptionhuman genetic material taglaboratory mousenutrition aspect of cancernutrition related tagteatranscription factor
项目摘要
DESCRIPTION (provided by applicant): There is persuasive epidemiological evidence that consumption of dietary polyphenolic plant-derived compounds reduce chronic disease such as cancer. Many laboratory studies including us have shown the inhibitory effect of dietary compounds including resveratrol, genistein, and diaryl disulfide against carcinogenesis in vivo and in vitro. Green tea and its constituent polyphenols (catechins) have been shown to possess anti-tumor properties in a wide variety of experimental systems. Some reports are suggesting an involvement of p53 tumor suppressor proteins, but others do not. Thus, the exact molecular mechanism by which green tea induce anti-tumorigenic effect is not clear. One promising mechanism is the induction of apoptosis by catechins. Indeed, catechins have been known to be associated with the induction of apoptosis. In this regard, our hypothesis of this novel proposal is that the cancer chemopreventive effect of green tea components including catechin (-) epigallocatechin 3-gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), and epicatechin (EC) is through the induction of apoptotic mechanisms involving the induction of a newly identified TGF-beta superfamily protein, NAG-1 (Nonsteroidal anti-inflammatory drug activated gene). The rationale for this hypothesis is based on the followings: 1) identification of the NAG-1 gene as a dietary induced gene, 2) higher NAG-1 expression in normal colonic epithelial than adjacent tumor cells, 3) NAG-1 has pro-apoptotic and anti-tumorigenic activities reported by us and other groups. Therefore, the overall goal of this project is to identify single catechins or the combinations of catechins for higher NGA-1 inducer in human colorectal cancer cells. To investigate the molecular mechanisms of which a green tea component or combination of them induces NAG-1 expression, we will use two different models, HCT- 116 human colorectal adenocarcinoma cells and mouse model system with following specific aims: 1. Define transcriptional regulatory mechanisms responsible for NAG-1 induction by ECG and other catechins. 2. Profile changes in gene expression following ECG treatment. 3. Compare the preventative and therapeutic efficacy of individual and combination catechins in animal models of colorectal cancer.
描述(由申请人提供):有令人信服的流行病学证据表明,食用植物源性多酚化合物可以减少癌症等慢性疾病。包括我们在内的许多实验室研究表明,膳食化合物(包括白藜芦醇、染料木黄酮和二芳基二硫化物)在体内和体外具有抗癌作用。绿茶及其成分多酚(儿茶素)已在各种实验系统中被证明具有抗肿瘤特性。一些报告表明 p53 肿瘤抑制蛋白参与其中,但其他报告则不然。因此,绿茶诱导抗肿瘤作用的确切分子机制尚不清楚。一种有前景的机制是儿茶素诱导细胞凋亡。事实上,已知儿茶素与细胞凋亡的诱导有关。在这方面,我们对这一新提案的假设是,包括儿茶素(-)表没食子儿茶素3-没食子酸酯(EGCG)、表儿茶素没食子酸酯(ECG)、表没食子儿茶素(EGC)和表儿茶素(EC)在内的绿茶成分的癌症化学预防作用是通过诱导细胞凋亡机制,包括诱导新鉴定的 TGF-β 超家族蛋白 NAG-1(非甾体抗炎药激活基因)。该假设的基本原理基于以下内容:1) NAG-1 基因被鉴定为饮食诱导基因,2) 正常结肠上皮细胞中的 NAG-1 表达高于邻近肿瘤细胞,3) NAG-1 具有亲我们和其他小组报告的细胞凋亡和抗肿瘤活性。因此,该项目的总体目标是鉴定单一儿茶素或儿茶素组合,以在人结直肠癌细胞中产生更高的 NGA-1 诱导剂。为了研究绿茶成分或其组合诱导 NAG-1 表达的分子机制,我们将使用两种不同的模型:HCT-116 人结直肠腺癌细胞和小鼠模型系统,其具体目标如下: 1. 定义转录调控机制负责通过 ECG 和其他儿茶素诱导 NAG-1。 2. ECG 治疗后基因表达的变化。 3.比较单独和组合儿茶素在结直肠癌动物模型中的预防和治疗效果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEUNG Joon BAEK其他文献
SEUNG Joon BAEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEUNG Joon BAEK', 18)}}的其他基金
Transcription Regulation and Biological Function of NAG1
NAG1的转录调控及生物学功能
- 批准号:
6799937 - 财政年份:2003
- 资助金额:
$ 12.45万 - 项目类别:
Transcription Regulation and Biological Function of NAG1
NAG1的转录调控及生物学功能
- 批准号:
6610681 - 财政年份:2003
- 资助金额:
$ 12.45万 - 项目类别:
Transcription Regulation and Biological Function of NAG1
NAG1的转录调控及生物学功能
- 批准号:
6910744 - 财政年份:2003
- 资助金额:
$ 12.45万 - 项目类别:
相似国自然基金
具有协同药效的金配合物前药分子设计、可控性活化和抗肿瘤活性研究
- 批准号:22377154
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
“减毒增效”—一类新型核苷类抗肿瘤前药的发现与生物学研究
- 批准号:82304303
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
荷载鞭毛蛋白的载药囊泡激发中性粒细胞抗肿瘤效应及其机制研究
- 批准号:82303724
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
光笼型Mcl-1抑制剂前药的构建与光活化靶向抗肿瘤作用研究
- 批准号:82304305
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
溶酶体靶向聚集性无药抗肿瘤纳米颗粒的研究
- 批准号:52303170
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Action of Chinese Medicinal Herbs on Prostate Cancer
中药对前列腺癌的作用
- 批准号:
7287969 - 财政年份:2005
- 资助金额:
$ 12.45万 - 项目类别:
Anticancer Potential of Black Cohosh on Breast Cancer
黑升麻对乳腺癌的抗癌潜力
- 批准号:
7011261 - 财政年份:2005
- 资助金额:
$ 12.45万 - 项目类别:
Anticancer Potential of Black Cohosh on Breast Cancer
黑升麻对乳腺癌的抗癌潜力
- 批准号:
6869839 - 财政年份:2005
- 资助金额:
$ 12.45万 - 项目类别:
The Action of Chinese Medicinal Herbs on Prostate Cancer
中药对前列腺癌的作用
- 批准号:
6834758 - 财政年份:2005
- 资助金额:
$ 12.45万 - 项目类别: